Otto-Henning Wilhelms

This inventor holds 22 USPTO granted patents, primarily in Pharmaceutical Compounds. Top assignees: Boehringer Mannheim Gmbh, Roche Diagnostics Gmbh. Active years: 1978-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Otto-Henning Wilhelms. Retrieved from https://idiyas.com/inventor/otto-henning-wilhelms

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 22

% Patents Active = 100.0

Average Co-Inventor Count = 3.6

ph-index = 9

Forward Citations = 302(Granted Patents)

Location History:

Heddesheim, DE (1978 - 1980)
Mannheim, DE (1990)
Weinheim-Rittenweimer, DE (1993)
Weinheim-Rittenweier, DE (1980 - 1995)
Weinheim, DE (2001)

Company Filing History:

21 out of 1,164

Boehringer Mannheim Gmbh

patents

1 out of 488

Roche Diagnostics Gmbh

patents

Years Active: 1978-2001

Loading Chart...

Areas of Expertise:

Thiadiazolo Derivatives

Pyridine Compounds

Macrolactones

Allergy Detection

Tetrazolyl Thioethers

Hydroxamic Acids

Pyrazolo Compounds

Adenosine Derivatives

Thioethers

Benzopyran Compounds

Coumarins

Xanthine Derivatives

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6326378 - Use of thiadiazolo[4,3-a]pyridine derivatives (2001-12-04),

2. 5399575 - Pyridine compounds which have useful pharmaceutical activity (1995-03-21),

3. 5217990 - Use of macrolactones as anti-allergics (1993-06-08),

4. 5116731 - Process for the detection of an allergy or an anti-allergic substance (1992-05-26),

5. 5025028 - Tetrazolyl substituted thioethers, pharmaceutical compositions and (1991-06-18),

6. 4906666 - Hydroxamic acids and pharmaceutical compositions containing them, and (1990-03-06),

7. 4904666 - Pyrazolo(3,4-d)pyrimidine compounds, compositions and method of use (1990-02-27),

8. 4853386 - N.sup.6 -disubstituted purine derivatives, and pharmaceutical (1989-08-01),

9. 4760077 - Pyrrothine derivatives and pharmaceutical use thereof (1988-07-26),

10. 4704381 - Use of adenosine derivatives as anti-allergic compounds and (1987-11-03),

11. 4621098 - Thioethers and pharmaceutical compositions containing them (1986-11-04),

12. 4592997 - Process for the detection of the presence of an allergy and for the (1986-06-03),

13. 4428955 - Benzopyran compounds, pharmaceutical compositions containing them and (1984-01-31),

14. 4427680 - 1,2-Dihydroquinolines connected via an oxyalkyl group with a piperidine (1984-01-24),

15. 4382943 - Anti-allergic aryl ether derivatives (1983-05-10),

Title: Innovations by Otto-Henning Wilhelms

Introduction

Otto-Henning Wilhelms is a notable inventor based in Weinheim-Rittenweier, Germany. He holds an impressive portfolio of 22 patents, reflecting his significant contributions to the field of pharmaceutical sciences. His research primarily focuses on compounds that have the potential to treat serious health conditions.

Latest Patents

Among his latest innovations, Wilhelms has developed a method for treating leukemia and lymphoma using thiadiazolo[4,3-a]pyridine derivatives. This invention targets the proliferation of cells, showcasing his commitment to advancing medical solutions. In addition, he has worked on a range of pyridine compounds that exhibit useful pharmaceutical activities, further underscoring his expertise in this area.

Career Highlights

Wilhelms has built a distinguished career working with leading companies in the pharmaceutical industry, including Boehringer Mannheim GmbH and Roche Diagnostics GmbH. His roles in these organizations have allowed him to drive forward-thinking innovations that address critical health issues.

Collaborations

Throughout his career, Otto-Henning Wilhelms has collaborated with esteemed colleagues such as Walter-Gunar Friebe and Androniki Roesch. These partnerships have been vital in the development and realization of his patented inventions, emphasizing the importance of teamwork in the pursuit of scientific advancements.

Conclusion

With a solid foundation of patents and collaborations, Otto-Henning Wilhelms continues to be a driving force in the world of pharmaceutical innovation. His commitment to research and development not only highlights his talent as an inventor but also contributes to the ongoing battle against serious health conditions through innovative treatments.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]